Who owns AKARI THERAPEUTICS PLC SPONSORED?
- Ticker: AKTX
- CUSIP Number: 00972g207
Tip: Access positions for across all investors
Analyze quarterly positions in Akari Therapeutics Plc Sponsored with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Akari Therapeutics Plc Sponsored stock
Who bought or sold AKARI THERAPEUTICS PLC SPONSORED this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Cresset Asset Management | 823k | $238k | 0% | Dec 2025 |
|
| Warberg Asset Management | 308k | $89k | 100% | Dec 2025 |
|
| Palo Alto Investors | 146k | $148k | 0% | Sep 2025 |
|
| HighTower Advisors | 79k | $23k | 0% | Dec 2025 |
|
| Jane Street | 72k | $21k | 100% | Dec 2025 |
|
| CWA Asset Management | 55k | $16k | 100% | Dec 2025 |
|
| XTX Topco | 49k | $14k | 100% | Dec 2025 |
|
| UBS Group | 33k | $9.5k | 54658% | Dec 2025 |
|
| HPM Partners | 24k | $6.8k | 0% | Dec 2025 |
|
| Intl Fcstone | 21k | $6.2k | 100% | Dec 2025 |
|
| Skyview Financial Group | 21k | $5.9k | 100% | Dec 2025 |
|
| Independent Advisor Alliance | 17k | $4.9k | 57% | Dec 2025 |
|
| Goss Wealth Management | 6.8k | $2.0k | 0% | Dec 2025 |
|
| Accent Capital Management | 5.0k | $1.4k | -50% | Dec 2025 |
|
| SBI Securities | 200.00 | $58.000000 | 100% | Dec 2025 |
|
| Truvestments Capital | 50.00 | $14.000000 | 0% | Dec 2025 |
|
| Cornerstone Planning Group | 5.00 | $1.000000 | -29% | Dec 2025 |
|
Who sold out of Akari Therapeutics Plc Sponsored?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Omnia Family Wealth | Sep 2025 | 28k | $29k |
| Virtu Financial | Sep 2025 | 23k | $22k |
| Two Sigma Securities | Sep 2025 | 20k | $20k |
| EverSource Wealth Advisors | Sep 2025 | 44.00 | $44.000000 |